About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Until 2017, this group was constituted as a consolidated group in the VHIR under the name of "Digestive Transplants" with a consolidated research trajectory. Our group has two large areas of research: liver transplantation, which is cross-sectional adult-pediatric and; on the other hand, research, specifically in the fields of liver resections, liver cancer (primary or metastatic), biliary cancer, pancreatic cancer and pancreatitis. Both areas have very innovative aspects, with translational objectives, including artificial intelligence, transcriptomics and molecular biology.
The general objective of the liver transplant research area is to improve the preservation of liver grafts, as well as increase the survival of grafts and transplant patients. The research area related to cancer or acute pancreatitis has as a general objective to improve the management and treatment of patients with pancreatitis, as well as to improve the diagnosis and survival of cancer patients.
IP: Elizabeth Pando Rau, Joaquin Balsells Valls
Colangiocarcinoma intrahepatic i perihiliar i les metàstasis hepàtiques colo-rectals irresecables.
IP: Cristina Dopazo Taboada, Ramon Charco Torra
Té com a objectiu avaluar el pronòstic en l'entorn preoperatori en comparació amb els factors clínics i histològics.
IP: Concepción Gomez Gavara Collaborators: - Funding agency: Instituto de Salud Carlos III Funding: 32670 Reference: PI20/00552 Duration: 01/01/2021 - 30/06/2025
IP: Beatriz Minguez Rosique Collaborators: Itxarone Izaskun Bilbao Aguirre, Elena Vargas Accarino, Maria Teresa Salcedo Allende, Monica Higuera Urbano Funding agency: Instituto de Salud Carlos III Funding: 183920 Reference: PI21/00714 Duration: 01/01/2022 - 31/12/2025
The donation will support a research line focused on understanding the progression of this inflammatory liver disease and improving treatment personalisation.
The document provides a comprehensive evaluation of current knowledge on this type of cancer affecting the bile ducts.
Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research
